Article ; Online: Blood Product Transfusion in Adults: Indications, Adverse Reactions, and Modifications.
2020 Volume 102, Issue 1, Page(s) 30–38
Abstract: Millions of units of blood products are transfused annually to patients in the United States. Red blood cells are transfused to improve oxygen-carrying capacity in patients with or at high risk of developing symptomatic anemia. Restrictive transfusion ... ...
Abstract | Millions of units of blood products are transfused annually to patients in the United States. Red blood cells are transfused to improve oxygen-carrying capacity in patients with or at high risk of developing symptomatic anemia. Restrictive transfusion thresholds with lower hemoglobin levels are typically clinically equivalent to more liberal thresholds. Transfusion of plasma corrects clinically significant coagulopathy in patients with or at high risk of bleeding. Mildly abnormal laboratory coagulation values are not predictive of clinical bleeding and should not be corrected with plasma. Transfused platelets prevent or treat bleeding in patients with thrombocytopenia or platelet dysfunction. Cryoprecipitate is transfused to treat hypofibrinogenemia. Many adverse reactions can occur during or after blood product transfusion. Transfusion-associated circulatory overload (i.e., volume overload) is the most common cause of mortality associated with blood products. Modifications to blood products can prevent or decrease the risks of transfusion-related adverse reactions. It is critical to quickly recognize when a reaction is occurring, stop the transfusion, assess, and support the patient. Reporting a reaction to the blood bank is part of ensuring patient safety and supporting hemovigilance efforts. |
---|---|
MeSH term(s) | Blood Component Transfusion/adverse effects ; Blood Component Transfusion/methods ; Hematologic Diseases/classification ; Hematologic Diseases/therapy ; Humans ; Patient Safety ; Practice Guidelines as Topic ; Risk Adjustment/methods ; Risk Assessment/methods ; Transfusion Reaction/classification ; Transfusion Reaction/etiology ; Transfusion Reaction/prevention & control |
Language | English |
Publishing date | 2020-08-05 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 412694-4 |
ISSN | 1532-0650 ; 0002-838X ; 0572-3612 |
ISSN (online) | 1532-0650 |
ISSN | 0002-838X ; 0572-3612 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 848: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.